Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vishal Unadkat, Shishir Rohit, Paranjay Parikh, Kaushal Patel, Vinod Sanna & Sanjay Singh. (2022) Identification of 1,2,4-Oxadiazoles-Based Novel EGFR Inhibitors: Molecular Dynamics Simulation-Guided Identification and in vitro ADME Studies. OncoTargets and Therapy 15, pages 479-495.
Read now
Read now
Oscar Ekpenyong, Xiuqing Gao, Jing Ma, Candace Cooper, Linh Nguyen, Omonike A Olaleye, Dong Liang & Huan Xie. (2020) Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases. Drug Design, Development and Therapy 14, pages 1263-1277.
Read now
Read now
Gergő Tóth, Ádám Jánoska, Zoltán-István Szabó, Gergely Völgyi, Gábor Orgován, Lajos Szente & Béla Noszál. (2016) Physicochemical characterisation and cyclodextrin complexation of erlotinib. Supramolecular Chemistry 28:7-8, pages 656-664.
Read now
Read now
Bianca K. Verlinden, Abraham Louw & Lyn-Marié Birkholtz. (2016) Resisting resistance: is there a solution for malaria?. Expert Opinion on Drug Discovery 11:4, pages 395-406.
Read now
Read now
Articles from other publishers (35)
T. Y. J. Appeldoorn, T. H. Oude Munnink, L. M. Morsink, M. N. Lub-de Hooge & D. J. Touw. (2023) Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review. Clinical Pharmacokinetics 62:4, pages 559-571.
Crossref
Crossref
Shahul H. Nilar. 2023. Big Data Analytics in Chemoinformatics and Bioinformatics. Big Data Analytics in Chemoinformatics and Bioinformatics
265
281
.
Raphael Lengacher, Youchao Wang, Henrik Braband, Olivier Blacque, Gilles Gasser & Roger Alberto. (2021) Organometallic small molecule kinase inhibitors – direct incorporation of Re and 99mTc into Opaganib®. Chemical Communications 57:98, pages 13349-13352.
Crossref
Crossref
Maximilian V. Schmitt, Andreas Reichel, Xiaohui Liu, Gert Fricker & Philip Lienau. (2021) Extension of the Mechanistic Tissue Distribution Model of Rodgers and Rowland by Systematic Incorporation of Lysosomal Trapping: Impact on Unbound Partition Coefficient and Volume of Distribution Predictions in the Rat. Drug Metabolism and Disposition 49:1, pages 53-61.
Crossref
Crossref
Ruhul Kayesh, Taleah Farasyn, Alexandra Crowe, Qiang Liu, Sonia Pahwa, Khondoker Alam, Sibylle Neuhoff, Oliver Hatley, Kai Ding & Wei Yue. (2021) Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences 110:1, pages 314-324.
Crossref
Crossref
Maria Tannous, Fabrizio Caldera, Gjylije Hoti, Umberto Dianzani, Roberta Cavalli & Francesco Trotta. 2021. Supramolecules in Drug Discovery and Drug Delivery. Supramolecules in Drug Discovery and Drug Delivery
247
283
.
Andrea Unzue, Claudia Jessen-Trefzer, Dimitrios Spiliotopoulos, Eugenio Gaudio, Chiara Tarantelli, Jing Dong, Hongtao Zhao, Johanna Pachmayr, Stefan Zahler, Elena Bernasconi, Giulio Sartori, Luciano Cascione, Francesco Bertoni, Paweł Śledź, Amedeo Caflisch & Cristina Nevado. (2020)
Understanding the mechanism of action of pyrrolo[3,2-
b
]quinoxaline-derivatives as kinase inhibitors
. RSC Medicinal Chemistry 11:6, pages 665-675.
Crossref
Crossref
Kyu-Mok Hwang, Sang-Yeop Kim, Thi-Tram Nguyen, Cheol-Hee Cho & Eun-Seok Park. (2019) Use of roller compaction and fines recycling process in the preparation of erlotinib hydrochloride tablets. European Journal of Pharmaceutical Sciences 131, pages 99-110.
Crossref
Crossref
Steven H. Spergel, Michael E. Mertzman, James Kempson, Junqing Guo, Sylwia Stachura, Lauren Haque, Jonathan S. Lippy, Rosemary F. Zhang, Michael Galella, Sidney Pitt, Guoxiang Shen, Aberra Fura, Kathleen Gillooly, Kim W. McIntyre, Vicky Tang, John Tokarski, John S. Sack, Javed Khan, Percy H. Carter, Joel C. Barrish, Steven G. Nadler, Luisa M. Salter-Cid, Gary L. Schieven, Stephen T. Wrobleski & William J. Pitts. (2019) Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. ACS Medicinal Chemistry Letters 10:3, pages 306-311.
Crossref
Crossref
Sai Manohar Chelli, Parth Gupta & Siva Kumar Belliraj. (2019) An in silico design of bioavailability for kinase inhibitors evaluating the mechanistic rationale in the CYP metabolism of erlotinib. Journal of Molecular Modeling 25:3.
Crossref
Crossref
Paresh P. Chothe, Shu-Pei Wu, Zhengqi Ye & Niresh Hariparsad. (2018) Assessment of Transporter-Mediated and Passive Hepatic Uptake Clearance Using Rifamycin-SV as a Pan-Inhibitor of Active Uptake. Molecular Pharmaceutics 15:10, pages 4677-4688.
Crossref
Crossref
Álvaro Lorente-Macías, Manuel Benítez-Quesada, Ignacio J. Molina, Asier Unciti-Broceta, Juan José Díaz-Mochón & María José Pineda de las Infantas Villatoro. (2018)
1
H and
13
C assignments of 6-, 8-, 9- substituted purines
. Magnetic Resonance in Chemistry 56:9, pages 852-859.
Crossref
Crossref
Yongkai Sun, Paresh P. Chothe, Jennifer E. Sager, Hong Tsao, Amanda Moore, Leena Laitinen & Niresh Hariparsad. (2017) Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction Predictions. Drug Metabolism and Disposition 45:6, pages 692-705.
Crossref
Crossref
Gaby A.M. Eliesen, Petra van den Broek, Jeroen J. van den Heuvel, Albert Bilos, Jeanne Pertijs, Joris van Drongelen, Frans G.M. Russel & Rick Greupink. (2017) Editor?s Highlight: Placental Disposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicological Sciences 157:2, pages 500-509.
Crossref
Crossref
. 2017. Cyclodextrins. Cyclodextrins
219
228
.
Sailu Sarvagalla & Mohane Selvaraj Coumar. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
1115
1143
.
Jin Han, Silje Henriksen, Kristin G. Nørsett, Eirik Sundby & Bård Helge Hoff. (2016) Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors. European Journal of Medicinal Chemistry 124, pages 583-607.
Crossref
Crossref
Chander Parkash Dora, Francesco Trotta, Varun Kushwah, Naresh Devasari, Charan Singh, Sarasija Suresh & Sanyog Jain. (2016) Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohydrate Polymers 137, pages 339-349.
Crossref
Crossref
Sailu Sarvagalla & Mohane Selvaraj Coumar. 2016. Applied Case Studies and Solutions in Molecular Docking-Based Drug Design. Applied Case Studies and Solutions in Molecular Docking-Based Drug Design
249
277
.
Steffen Bugge, Audun Formo Buene, Nathalie Jurisch-Yaksi, Ingri Ullestad Moen, Ellen Martine Skj?nsfjell, Eirik Sundby & B?rd Helge Hoff. (2016) Extended structure?activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties. European Journal of Medicinal Chemistry 107, pages 255-274.
Crossref
Crossref
Peng Wu, Thomas E. Nielsen & Mads H. Clausen. (2016) Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. Drug Discovery Today 21:1, pages 5-10.
Crossref
Crossref
Steven Howard. 2015. Fragment-Based Drug Discovery. Fragment-Based Drug Discovery
153
176
.
Andrea Astolfi, Nunzio Iraci, Giuseppe Manfroni, Maria Letizia Barreca & Violetta Cecchetti. (2015) A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors. ChemMedChem 10:6, pages 957-969.
Crossref
Crossref
Mark C. Munson. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
329
364
.
Saktimayee M. Roy, Valerie L. Grum-Tokars, James P. Schavocky, Faisal Saeed, Agnieszka Staniszewski, Andrew F. Teich, Ottavio Arancio, Adam D. Bachstetter, Scott J. Webster, Linda J. Van Eldik, George Minasov, Wayne F. Anderson, Jeffrey C. Pelletier & D. Martin Watterson. (2015) Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models. ACS Chemical Neuroscience 6:4, pages 666-680.
Crossref
Crossref
Leah S. Imlay, Christopher M. Armstrong, Mary Clare Masters, Ting Li, Kathryn E. PriceRachel L. Edwards, Katherine M. Mann, Lucy X. Li, Christina L. Stallings, Neil G. BerryPaul M. O’NeillAudrey R. Odom. (2015)
Plasmodium
IspD (2-C-Methyl-
d
-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target
. ACS Infectious Diseases 1:4, pages 157-167.
Crossref
Crossref
Cecilia Russell, Andrew J. S. Lin, Peter Hains, Michela I. Simone, Phillip J. Robinson & Adam McCluskey. (2015) An integrated flow and microwave approach to a broad spectrum protein kinase inhibitor. RSC Advances 5:113, pages 93433-93437.
Crossref
Crossref
Maria J. Pineda de las Infantas, Sara Torres-Rusillo, Juan Diego Unciti-Broceta, Pablo Fernandez-Rubio, Maria Angelica Luque-GonzalezMiguel A. Gallo, Asier Unciti-Broceta, Ignacio J. Molina & Juan J. Diaz-Mochon. (2015) Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors. Organic & Biomolecular Chemistry 13:18, pages 5224-5234.
Crossref
Crossref
Rosie A. Johnston, Tristan Rawling, Ting Chan, Fanfan Zhou & Michael Murray. (2014) Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors. Drug Metabolism and Disposition 42:11, pages 1851-1857.
Crossref
Crossref
Vadim Bernard-Gauthier & Ralf Schirrmacher. (2014) 5-(4-((4-[18F]fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: A selective dual inhibitor for potential PET imaging of Trk/CSF-1R. Bioorganic & Medicinal Chemistry Letters 24:20, pages 4784-4790.
Crossref
Crossref
Andrea Unzue, Jing Dong, Karine Lafleur, Hongtao Zhao, Emilie Frugier, Amedeo Caflisch & Cristina Nevado. (2014)
Pyrrolo[3,2-
b
]quinoxaline Derivatives as Types I
1/2
and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and
in Vivo
Validation
. Journal of Medicinal Chemistry 57:15, pages 6834-6844.
Crossref
Crossref
Katherine T. Andrews, Gillian Fisher & Tina S. Skinner-Adams. (2014) Drug repurposing and human parasitic protozoan diseases. International Journal for Parasitology: Drugs and Drug Resistance 4:2, pages 95-111.
Crossref
Crossref
Francesca Carlomagno & Mario Chiariello. (2014) Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy. Journal of Molecular Medicine 92:7, pages 723-733.
Crossref
Crossref
Alberto Ramírez, Houria Boulaiz, Cynthia Morata-Tarifa, Macarena Perán, Gema Jiménez, Manuel Picon-Ruiz, Ahmad Agil, Olga Cruz-López, Ana Conejo-García, Joaquín M. Campos, Ana Sánchez, María A. García & Juan A. Marchal. (2014) HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib. Oncotarget 5:11, pages 3590-3606.
Crossref
Crossref
James I. Murray, Rudiger Woscholski & Alan C. Spivey. (2014) Highly efficient and selective phosphorylation of amino acid derivatives and polyols catalysed by 2-aryl-4-(dimethylamino)pyridine-N-oxides – towards kinase-like reactivity. Chem. Commun. 50:88, pages 13608-13611.
Crossref
Crossref